It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Staphylococcus aureus is a common cause of catheter-related blood stream infections (CRBSI). The bacterium has the ability to form multilayered biofilms on implanted material, which usually requires the removal of the implanted medical device. A first major step of this biofilm formation is the initial adhesion of the bacterium to the artificial surface. Here, we used single-cell force spectroscopy (SCFS) to study the initial adhesion of S. aureus to central venous catheters (CVCs). SCFS performed with S. aureus on the surfaces of naïve CVCs produced comparable maximum adhesion forces on three types of CVCs in the low nN range (~ 2–7 nN). These values were drastically reduced, when CVC surfaces were preincubated with human blood plasma or human serum albumin, and similar reductions were observed when S. aureus cells were probed with freshly explanted CVCs withdrawn from patients without CRBSI. These findings indicate that the initial adhesion capacity of S. aureus to CVC tubing is markedly reduced, once the CVC is inserted into the vein, and that the risk of contamination of the CVC tubing by S. aureus during the insertion process might be reduced by a preconditioning of the CVC surface with blood plasma or serum albumin.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Saarland University, Institute for Medical Microbiology and Hygiene, Homburg, Germany (GRID:grid.11749.3a) (ISNI:0000 0001 2167 7588)
2 Saarland University, Experimental Physics, Saarbrucken, Germany (GRID:grid.11749.3a) (ISNI:0000 0001 2167 7588)
3 Saarland University, Clinic of Operative Dentistry and Periodontology, Homburg, Germany (GRID:grid.11749.3a) (ISNI:0000 0001 2167 7588)
4 Saarland University, Department of Internal Medicine V, Pneumology and Intensive Care Medicine, Homburg, Germany (GRID:grid.11749.3a) (ISNI:0000 0001 2167 7588)
5 Saarland University, Experimental Physics, Saarbrucken, Germany (GRID:grid.11749.3a) (ISNI:0000 0001 2167 7588); Max Planck School Matter to Life, Heidelberg, Germany (GRID:grid.4372.2) (ISNI:0000 0001 2105 1091)